Alpha-9 Theranostics is a clinical-stage, radiopharmaceutical company based in Vancouver using molecularly targeted radiopharmaceuticals for the improved diagnosis and treatment of metastatic cancer. The Company is developing new theranostic products based on breakthrough technology developed by the scientific founders and exclusively licensed from the University of British Columbia and BC Cancer.